Considering recent findings,33 it is further worth exploring whether GLP-1 or dual GIP/GLP-1 receptor agonists could prevent dementia in stroke patients with prediabetes and obesity by preventing the progression to diabetes. The gene discussed is GIP; the disease is obesity disorder.